Latest News

China’s Sinotau nets $152m to advance its radiopharmaceutical pipeline ahead of IPO


share this article!

Photo by Myriam Zilles on Unsplash

Beijing Sinotau International Pharmaceutical Technology (Sinotau) has secured over 1.1 billion yuan ($151.8 million) in a new funding round to advance the R&D and clinical trials of its radiopharmaceutical pipeline, the firm announced on Monday.

Read More

share this article!

People Digest: Lawrence Wong named MAS chair, PAG Asia partner Kim retires

Previous article

3 Stocks to Avoid This Week @themotleyfool #stocks $MO $WBA $FUL $CVNA $LEVI $JOBY

Next article

You may also like


Leave a reply

Your email address will not be published. Required fields are marked *

More in Latest News